Which COVID-19 vaccine should I get?

Should I try and get an mRNA vaccine? They are better than the others, aren’t they? If I show up at the clinic can I choose?

 These are some of the questions that we didn’t even know we would be so lucky to ask just three months ago. 

The speed at which multiple vaccines to choose from has come about is unprecedented. 

The first genome sequence of a previously unknown virus was published in early January 2020 and the Pfizer and Moderna mRNA vaccines, tested over the summer and fall of 2020, were approved for emergency use in early December. 

These are the quickest vaccines ever developed. Their very speed has raised a lot of questions around their safety. It is true that all previous vaccines have taken years to develop and the cumulative experience of their use over time is reassuring. 

Moderate reactions

Nevertheless the COVID-19 vaccines have been tested in very big trials. As a comparison, the widely used and “uncontroversial” Shingrix vaccine for prevention of shingles was tested in 32,000 participants prior to submission for approval in 2017. The total number of patients in COVID-19 vaccine trials that have reported results so far is 170,000 and growing rapidly. 

The safety results have been reassuring — both in the trial participants and now in millions of people worldwide who have been vaccinated and reported to national monitoring systems. 

Rates of severe side effects, mainly anaphylaxis, have been very rare — a handful in every million vaccinated — and the more common reactions such as arm pain, fever, fatigue and muscle aches have been over very quickly. 

The brief discomfort of COVID-19 vaccines seems to be greater than for the annual flu shot. This probably reflects a combination of both the “prime-boost” two-shot strategy to provoke maximum stimulation of the immune system; and the large group of vaccinees who were recently infected naturally with SARS-CoV-2 and already have a naturally primed immune system ready to react. Maybe the single-shot Johnson & Johnson vaccine will have fewer reactions?

Don’t compare
the numbers

There are now three vaccines available in the USA (Pfizer, Moderna and Johnson & Johnson) and several more globally, with more to come. 

Inevitable comparisons between the different vaccines, using their “headline” efficacy numbers, is a favorite media story at the moment. This has stimulated “vaccine shopping,” which has reached damaging levels in places like Germany, where the UK Astra-Zeneca vaccine sits un-used in warehouses whilst people wait, unprotected, for the Pfizer vaccine. 

The efficacy numbers attached to the two shots is responsible for this: 95% for Pfizer versus 62% for Astra-Zeneca. 

These numbers are a snapshot in time and can’t be compared with each other. 

Different vaccine trials

The Pfizer number was generated from a trial mainly in the USA, where most of the patients were recruited in the summer and fall of 2020. 

The Astra-Zeneca number was reported from a trial that included a substantial mixture of patients from the UK, South Africa and Brazil. 

The Pfizer and Moderna trials closely adhered to the three- or four-week interval between doses, whereas the Astra-Zeneca trial had a less strict timing. 

The different trials measured infection and symptoms in different ways at different time points. 

In more recent trials — for example the Johnson & Johnson and Novavax trials — there were large numbers of infections with new virus variants included as well. 

The efficacy result of each trial is reflective of the performance of the vaccine WITHIN that trial compared with a placebo — but not comparable OUTSIDE of the trial with the other vaccines.

Real-world results

To emphasize this, we have recent large-scale program results from the Scottish National Health Service. 

The Astra-Zeneca vaccine has been 94% effective in reducing hospitalizations so far compared with the Pfizer vaccine, which has been 85% effective. 

This reversal of efficacy rankings in a real-world observation simply emphasizes that both vaccines are great. 

The most important number of all to remember is that in the thousands and thousands of trial participants who received any of the vaccines there were no COVID deaths and almost no hospitalizations for COVID.

So when you have finally managed to find your vaccine appointment after refreshing the sign-up page a hundred times and been booked four weeks hence, don’t worry about which vaccine you will get. Just pick the one with the smallest needle.

 

James Shepherd, MD PhD, lives in Sharon, Conn., and is an Infectious Disease physician and epidemiologist who is on the faculty of the Yale University School of Medicine.

Latest News

Habitat for Humanity brings home-buying pilot to Town of North East

NORTH EAST — Habitat for Humanity of Dutchess County will conduct a presentation on Thursday, May 9 on buying a three-bedroom affordable home to be built in the Town of North East.

The presentation will be held at the NorthEast-Millerton Library Annex at 5:30 p.m.

Keep ReadingShow less
The artist called ransome

‘Migration Collage' by ransome

Alexander Wilburn

If you claim a single sobriquet as your artistic moniker, you’re already in a club with some big names, from Zendaya to Beyoncé to the mysterious Banksy. At Geary, the contemporary art gallery in Millerton founded by New Yorkers Jack Geary and Dolly Bross Geary, a new installation and painting exhibition titled “The Bitter and the Sweet” showcases the work of the artist known only as ransome — all lowercase, like the nom de plume of the late Black American social critic bell hooks.

Currently based in Rhinebeck, N.Y., ransome’s work looks farther South and farther back — to The Great Migration, when Jim Crow laws, racial segregation, and the public violence of lynching paved the way for over six million Black Americans to seek haven in northern cities, particularly New York urban areas, like Brooklyn and Baltimore. The Great Migration took place from the turn of the 20th century up through the 1970s, and ransome’s own life is a reflection of the final wave — born in North Carolina, he found a new home in his youth in New Jersey.

Keep ReadingShow less
Four Brothers ready for summer season

Hospitality, ease of living and just plain fun are rolled into one for those who are intrigued by the leisure-time Caravana experience at the family-owned Four Brothers Drive-in in Amenia. Tom Stefanopoulos, pictured above, highlights fun possibilities offered by Hotel Caravana.

Leila Hawken

The month-long process of unwrapping and preparing the various features at the Four Brothers Drive-In is nearing completion, and the imaginative recreational destination will be ready to open for the season on Friday, May 10.

The drive-in theater is already open, as is the Snack Shack, and the rest of the recreational features are activating one by one, soon to be offering maximum fun for the whole family.

Keep ReadingShow less
Sun all day, Rain all night. A short guide to happiness and saving money, and something to eat, too.
Pamela Osborne

If you’ve been thinking that you have a constitutional right to happiness, you would be wrong about that. All the Constitution says is that if you are alive and free (and that is apparently enough for many, or no one would be crossing our borders), you do also have a right to take a shot at finding happiness. The actual pursuit of that is up to you, though.

But how do you get there? On a less elevated platform than that provided by the founding fathers I read, years ago, an interview with Mary Kay Ash, the founder of Mary Kay Cosmetics. Her company, based on Avon and Tupperware models, was very successful. But to be happy, she offered,, you need three things: 1) someone to love; 2) work you enjoy; and 3) something to look forward to.

Keep ReadingShow less